Cefacetrile
From Wikipedia, the free encyclopedia
|
Cefacetrile
|
|
| Systematic (IUPAC) name | |
| (6R,7R)-3-(acetyloxymethyl)-7-[(2-cyanoacetyl)amino]- 8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid |
|
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| Chemical data | |
| Formula | C13H13N3O6S |
| Mol. mass | 339.325 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 23 to 38% |
| Metabolism | ? |
| Half life | 1.2 hours |
| Excretion | Renal (72%) |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Intravenous, intramuscular |
Cefacetrile (INN, also spelled cephacetrile) is a broad-spectrum first generation cephalosporin antibiotic effective in Gram-positive and Gram-negative bacterial infections. It is a bacteriostatic antibiotic. Cefacetrile is marketed under the trade names Celospor, Celtol, and Cristacef.
|
||||||||||||||||||||

